Dr Lal PathLabs Q3 Results: Net profit drops 6%, revenue up 11%
Published on 30/01/2026 02:01 PM
Dr Lal PathLabs Q3 Results: Net profit drops 6%, revenue up 11%Dr Lal PathLabs Q3 Results: The company's EBITDA climbed 17% year-on-year to ₹179 crore, while EBITDA margin expanded to 27.1%.By CNBCTV18.com January 30, 2026, 2:01:52 PM IST (Published)1 Min ReadDr Lal PathLabs on Friday, January 30, reported a mixed set of numbers for the December quarter.
Net profit fell 6.4% year-on-year to ₹90.5 crore in Q3, compared with ₹96.7 crore in the same period last year.
Revenue, however, rose 10.8% to ₹660 crore from ₹595.7 crore.
Operating performance remained strong during the quarter, with EBITDA climbing 17.3% year-on-year to ₹179 crore from ₹152.7 crore.
As a result, EBITDA margin expanded to 27.1%, compared with 25.6% a year ago.
Following the earnings announcement, shares of Dr Lal PathLabs Ltd. were trading 0.13% higher at ₹1,397.Continue ReadingTagsDr Lal Path LabsDr Lal Pathlabs